Skip to content
DraconiticResearch
Search Sources API
190,869 studies31 sourcesUpdated 40 min ago
PreprintCC BY-NC-NDmedRxiv

Human in vivo immunology of tuberculosis is not affected by sex dimorphism.

  1. 1Institute of Infection, Immunity and Transplantation, University College London, United Kingdom.

Abstract

Males incur greater risk of tuberculosis (TB) than females, but the contribution of sex-associated immune differences remains unclear. We addressed this using sex-stratified transcriptomic analyses across four independent studies spanning active pulmonary TB, subclinical TB and latent infection, in peripheral blood, bronchoalveolar lavage (BAL) and by using the tuberculin skin test (TST) as a standardised in vivo antigenic challenge. In blood of active TB patients, expression of TNF- and type I interferon-regulated signatures, genome-wide gene expression, and performance of leading host-response biomarkers of TB were comparable between sexes. Similarly, blood transcriptomic biomarkers showed no meaningful sex-related differences for predicting asymptomatic or incident TB. In the TST of people with latent infection, bulk and single-cell RNA sequencing identified only limited differences, largely restricted to sex chromosome-linked transcripts, with no consistent evidence of dimorphism in immune-regulated pathways. Single-cell RNA sequencing of BAL samples identified reduced abundance of B cells in male TB patients, with gene expression differences again largely restricted to sex chromosome-linked transcripts. These findings suggest that canonical immune responses associated with TB are broadly similar between the sexes, and that increased TB risk among males more likely reflects differential exposure rather than intrinsic immunological susceptibility.

Related

  1. Editorial: Immunology of human fungal pathogens: host-pathogen interactions, immune evasion, and therapeutic strategies
    Iván Martínez-Duncker, Andrea Regina de Souza Baptista, Héctor M. Mora Montes
    Frontiers in ImmunologyPeer-reviewedCC BY 4.0Full textInfectious diseaseCrossref
  2. The impact of social protection interventions on treatment and socioeconomic outcomes of tuberculosis-affected people and households in low income, high burden settings: A systematic review and meta-analysis
    Mollie Hudson, Heather Todd, Talemwa Nalugwa +5
    PLOS Global Public HealthPeer-reviewedCC BY 4.0Full text1 citedStatisticsClinical trials & evidence synthesisPLOS
  3. Costs faced by households affected by tuberculosis in the Republic of Korea: a mixed-methods study
    Kyung Hyun Oh, Minjoo Yang, Doosoo Jeon +15
    BMC Public HealthPeer-reviewedCC BY 4.0Infectious diseaseCrossref
  4. The Global Burden of Migraine: From Headache Days to Migraine-Affected Days—A Real-World Perspective on the Human and Societal Impact of Migraine
    Alin Ciubotaru, Albert Vamanu, Gabriela Popescu +11
    Medicina (Kaunas, Lithuania)Peer-reviewedCC BYFull textGeneral medicineEurope PMC
  5. Ex vivo human tumor slices more accurately predict patient responses to an oncolytic virus than in vivo mouse models
    J. Maldonado, T. Wong, J.-S. Leu +19
    bioRxivPreprintAll rights reservedFull textOncologybioRxiv
BibTeX
@misc{jiang2026human,
  title = {{Human in vivo immunology of tuberculosis is not affected by sex dimorphism.}},
  author = {J. Jiang and J. Greenan-Barrett and R. K. Gupta and M. Noursadeghi and C. T. Turner},
  howpublished = {medRxiv},
  year = {2026},
  month = jul,
  doi = {10.64898/2026.07.20.26358462},
  url = {https://www.medrxiv.org/content/10.64898/2026.07.20.26358462v2},
  note = {CC BY-NC-ND},
}
RIS
TY  - UNPB
TI  - Human in vivo immunology of tuberculosis is not affected by sex dimorphism.
AU  - J. Jiang
AU  - J. Greenan-Barrett
AU  - R. K. Gupta
AU  - M. Noursadeghi
AU  - C. T. Turner
PY  - 2026
DA  - 2026/07/20
PB  - medRxiv
DO  - 10.64898/2026.07.20.26358462
UR  - https://www.medrxiv.org/content/10.64898/2026.07.20.26358462v2
AB  - Males incur greater risk of tuberculosis (TB) than females, but the contribution of sex-associated immune differences remains unclear. We addressed this using sex-stratified transcriptomic analyses across four independent studies spanning active pulmonary TB, subclinical TB and latent infection, in peripheral blood, bronchoalveolar lavage (BAL) and by using the tuberculin skin test (TST) as a standardised in vivo antigenic challenge. In blood of active TB patients, expression of TNF- and type I interferon-regulated signatures, genome-wide gene expression, and performance of leading host-response biomarkers of TB were comparable between sexes. Similarly, blood transcriptomic biomarkers showed no meaningful sex-related differences for predicting asymptomatic or incident TB. In the TST of people with latent infection, bulk and single-cell RNA sequencing identified only limited differences, largely restricted to sex chromosome-linked transcripts, with no consistent evidence of dimorphism in immune-regulated pathways. Single-cell RNA sequencing of BAL samples identified reduced abundance of B cells in male TB patients, with gene expression differences again largely restricted to sex chromosome-linked transcripts. These findings suggest that canonical immune responses associated with TB are broadly similar between the sexes, and that increased TB risk among males more likely reflects differential exposure rather than intrinsic immunological susceptibility.
ER  -